Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

FDA recall notice · announced September 21, 2022 · Remedyrepack

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Reason for recall

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Notes

Distribution: Distributed to two direct accounts in PA and AK.
Lot/code information: Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023
Quantity: 1,699 blister cards/30 tablets each
Status: Terminated
Products in this recall event:
- Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00 (D-1538-2022)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.